GI & Endoscopy

GI ASC market not deterred by COVID-19, could hit $10.27B by 2027

The U.S. gastroenterology ASC market was worth $7.21 billion in 2019 and is expected to grow at a compound annual growth rate of 5.8 percent through 2027 to hit $10.27 billion, according to a Reports Globe report.

By: Staff

Tuesday, August 25th, 2020

Leading companies in the market include:

Olympus
Johnson & Johnson
Medtronic
GE Healthcare
Boston Scientific
Cardinal Health

The majority of centers are either affiliated with a hospital, freestanding or physician-owned.

More articles on surgery centers:
3 ASC developments worth over $10M
7 critical steps for financial success in your ASC
10 most common procedures in ASCs

Next Up in GI & Endoscopy

Colorado GI group settles class-action lawsuit over cyberattack

Lakewood, Colo.-based Rocky Mountain Gastroenterology has agreed to settle a class-action lawsuit stemming from a September 2024 data breach that…

By: Patsy Newitt
17 hours ago
SGMC Health adds 2 gastroenterologists

Valdosta, Ga.-based SGMC Health has added two GI physicians to its staff. C. Allen Woods, MD, and Riaz Gill, MD,…

By: Cameron Cortigiano
17 hours ago
Where GI practices are struggling, succeeding

Gastroenterologists are navigating a challenging healthcare environment as physician shortages, burnout and other market pressures continue to pose obstacles to…

By: Francesca Mathewes
19 hours ago

Comments are closed.

The future of perioperative care: Orchestrating efficiency across every role

Next Up in GI & Endoscopy

Colorado GI group settles class-action lawsuit over cyberattack

SGMC Health adds 2 gastroenterologists

Where GI practices are struggling, succeeding

Join the 40,000+ ASC leaders who start their day with Becker's